NASDAQ: ZVSA
Zyversa Therapeutics Inc Earnings Dates, Reports, Calls

Zyversa Therapeutics earnings were -$21.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest ZVSA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$2.4M, down 13.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ZVSA reported annual earnings of -$106.2M, with 341.5% growth.

ZVSA earnings history

Current Revenue
$0.0
Current Earnings
-$21.3M
Current Profit Margin
0%

ZVSA Return on Equity

Current Company
-224.9%
Current Industry
19.9%
Current Market
35%
ZVSA's Return on Equity (-224.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ZVSA undefined

Current Company
-103.2%
Current Industry
1.3%
ZVSA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZVSA announces earnings.

ZVSA undefined

Current Company
-276.39%
Current Industry
14.3%

ZVSA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZVSA-$21.78M-$21.33MN/A$575.93
KZIA-$16.35M-$17.39MN/A-$6.60
THAR-$10.84M-$10.85MN/A$61.43
BPTH-$10.36M-$10.51MN/A-$10.97
CERON/AN/AN/AN/A

Zyversa Therapeutics Earnings Reports & History FAQ

What were Zyversa Therapeutics's earnings last quarter?

Zyversa Therapeutics (NASDAQ: ZVSA) reported Q3 2024 earnings per share (EPS) of -$2.43, up 91.95% year over year. Total ZVSA earnings for the quarter were -$2.40 million. In the same quarter last year, Zyversa Therapeutics's earnings per share (EPS) was -$30.18.

If you're new to stock investing, here's how to buy Zyversa Therapeutics stock.

Is Zyversa Therapeutics profitable or losing money?

As of the last Zyversa Therapeutics earnings report, Zyversa Therapeutics is currently losing money. Zyversa Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$21.33 million, a 76.18% decrease year over year.

What was ZVSA's earnings growth in the past year?

As of Zyversa Therapeutics's earnings date in Q1 2025, Zyversa Therapeutics's earnings has grown year over year. ZVSA earnings in the past year totalled -$21.33 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.